Healthcare entity
medical-devices is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Regentis Biomaterials Ltd, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 3.1 for the same window.
Last mentioned: Aug 1, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
medical-devices is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Regentis Biomaterials Ltd, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 3.1 for the same window. The 7 average consequence score is above the beat benchmark of 6.3 in the same window. GelrinC appears in 1 tracked Healthcare story from March 17, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 34 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering GelrinC. Shared-story counts are live from our verified record — not editorial picks.
Regentis Biomaterials has patented a breakthrough solvent-free manufacturing process for its GelrinC hydrogel, achieving a 400% increase in production yield. This advancement positions the company for large-scale commercialization while improving the environmental profile and cost-efficiency of its cartilage repair solution.
Source: finanznachrichten.de · tennesseedaily.com
GelrinC is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
